BeiGene, Ltd. Company Information
BeiGene, Ltd.'s employee growth, exchange listings and data sources
Key Information
- Name: BeiGene, Ltd.
- Ticker: BGNE
- Exchange: NasdaqGS
- Founded: 2010
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$18.752b
- Shares Outstanding: 106.25m
- Website: https://www.beigene.com
Number of Employees
Location
- BeiGene, Ltd.
- 94 Solaris Avenue
- Camana Bay
- Grand Cayman
- KY1-1108
- Cayman Islands
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| BGNE | NasdaqGS (Nasdaq Global Select) | Yes | SPON ADS EACH REPR 13 ORD | US | USD | Feb 2016 |
| 49BA | DB (Deutsche Boerse AG) | Yes | SPON ADS EACH REPR 13 ORD | DE | EUR | Feb 2016 |
| BGNE N | BMV (Bolsa Mexicana de Valores) | Yes | SPON ADS EACH REPR 13 ORD | MX | MXN | Feb 2016 |
| 49B | DB (Deutsche Boerse AG) | Foreign Shares-Foreign Listed | DE | EUR | Aug 2018 | |
| 6160 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Foreign Shares-Foreign Listed | HK | HKD | Aug 2018 | |
| 6160 | SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect) | Foreign Shares-Foreign Listed | HK | HKD | Aug 2018 | |
| 6160 | SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect) | Foreign Shares-Foreign Listed | HK | HKD | Aug 2018 | |
| BEIG.F | OTCPK (Pink Sheets LLC) | Foreign Shares-Foreign Listed | US | USD | Aug 2018 | |
| 688235 | SHSE (Shanghai Stock Exchange) | Domestic Shares | CN | CNY | Dec 2021 | |
| 688235 | XSSC (Shanghai Stock Exchange - Shanghai - Hong Kong Stock Connect) | Domestic Shares | CN | CNY | Dec 2021 | |
| B1GN34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH 25 REPR 1 ADR | BR | BRL | Sep 2022 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 01:58 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BeiGene, Ltd. is covered by 57 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Brian Skorney | Baird |
| Michael Meng | BOCI Research Ltd. |
| Yonglin Yan | BOCI Research Ltd. |